China's medical products administrator granted MGI Tech (SHA:688114) subsidiary Qingdao MGI Intelligent Manufacturing Technology medical device approval for its gene sequencer, according to a Tuesday filing with the Shanghai Stock Exchange.
The gene sequencer is used in human DNA samples to help with the diagnosis of diseases, the filing said.
Shares rose 2% during Tuesday's late morning trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.